The global animal health company IDT Biologika has established a new organisation to serve the animal health needs of veterinarians, farmers and government agencies in the Americas and has marked its expansion by launching Ecoporc SHIGA, the first fully licensed swine vaccine for the Canadian market.
“The new organisation further strengthens IDT’s presence around the globe and unites all quality animal health development, production, approval and distribution activities for the Americas under one umbrella,” said Andreas Kastenbauer, head of IDT’s global animal health division.
The new division will be headed by José Ochoa (pictured above), who will be responsible for the overall growth and operations of the Americas business.
“IDT brings to the Americas deep and broad disease fighting expertise in a wide range of animal health conditions,” said Mr. Ochoa.
“We are currently building a sales network for solutions in swine diseases and our pipeline products. The company will continue to invest in the people and infrastructure needed to realise our full potential and to support future expansion into Latin America.”
Ecoporc SHIGA Swine Vaccine
IDT Biologika also concurrently launched its first fully licensed swine vaccine for Canada during the Banff Pork Seminar.
“Ecoporc SHIGA is an innovative vaccine that reduces clinical symptoms, animal losses and antibiotic use related to edema disease in swine,” said the company.
“Edema disease is an acute, often fatal, enterotoxemia of recently weaned pigs caused by specific virotypes of Shiga toxin-producing Escherichia coli. Edema disease causes serious losses to the pig industry, resulting in a high rate of mortality among infected pigs.
“Vaccines like Ecoporc SHIGA are vitally important to animal welfare, disease prevention and consumer protection. By reducing antibiotic use, vaccination is a modern solution contributing to public health. The product, which has been granted Canadian-wide approval last year, will soon be available to veterinarians and farmers.”
